- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A TRH analog (DN-1417). Blood level and brain distribution determined by radioimmunoassay after intravenous administration in rats.
-
- NAGAI Yasuo
- Central Research Division, Takeda Chemical Industries, Ltd.
-
- NARUMI Shigehiko
- Central Research Division, Takeda Chemical Industries, Ltd.
-
- SAJI Yoshiaki
- Central Research Division, Takeda Chemical Industries, Ltd.
-
- NAGAWA Yuji
- Central Research Division, Takeda Chemical Industries, Ltd.
Bibliographic Information
- Other Title
-
- TRH類縁体(DN‐1417) 静脈内投与後のラットにおける血中濃度および脳内分布
- TRH ルイエンタイ DN-1417 ジョウミャクナイ トウヨゴ ノ ラット
- Blood level and brain distribution determined by radioimmunoassay after intravenous administration in rats
Search this article
Description
Thyrotropin-releasing hormone (TRH) and its analog, DN-1417 (γ-butyrolactone-γ-carbonyl-L-histidyl-L-prolinamide citrate), were administered intravenously to rats, and the blood level and brain distribution were determined by a specific radioimmunoassay. Degradation half-life of DN-1417 in the brain homogenate and blood was 27.5 min and those of TRH were 5 and 7.5 min, respectively. After the administration of DN-1417 (0.625, 2.5 and 10 mg/kg), the blood levels of immunoreactive-DN-1417 exhibited an apparent two compartment open model. The half-life values of the α- and β-phase were 3 ?? 7 and 15 ?? 22 min, respectively. The half-life of the blood level of immunoreactive-DN-1417 was 2 ?? 3 times longer than that of TRH. As a result, the area under the curve of DN-1417 was 2.5 ?? 6 times larger than that of TRH. Blood level of immunoreactive-2-hydroxy-4-carboxybutyryl-histidyl-prolinamide (DN-COOH), a main metabolite of DN-1417, was not more than 1% of the immunoreactive DN-1417 level. The distribution of DN-1417 into whole brain was attained its peak at 1 ?? 2 min after the administration. The percentage of transported DN-1417 into the brain at peak time was 0.062-0.163% of each of the doses administered. After the administration of DN-1417 (2.5 mg/kg), the pituitary, nucleus accumbens and hypothalamus showed higher concentrations, while the striatum showed the lowest concentration in the brain tissue examined.
Journal
-
- Folia Pharmacologica Japonica
-
Folia Pharmacologica Japonica 85 (4), 231-242, 1985
The Japanese Pharmacological Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679249251584
-
- NII Article ID
- 130000761768
- 10007531243
-
- NII Book ID
- AN00198335
-
- COI
- 1:CAS:528:DyaL2MXktlWqs78%3D
-
- ISSN
- 13478397
- 00155691
-
- NDL BIB ID
- 3037938
-
- PubMed
- 3924797
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed